A (b)(6) male patient with newly diagnosed glioblastoma (gbm) began optune therapy on (b)(6) 2020.On (b)(6) 2022, novocure received a report that during a transducer array change on (b)(6) 2022, the visiting nurse observed an ulcer with exposed cranial hardware on the patient's scalp.Optune therapy was temporarily discontinued.On (b)(6) 2022, the prescribing physician reported, the cause of the event was a combination of prior craniotomies (last surgical resection (b)(6) 2020), radiation therapy, and optune therapy.The event was assessed as serious as plastic surgery suggested surgery might be necessary.
|